NUTRALIFE BIOSCIENCE

Item 7.01 Regulation FD Disclosure

On November 12, 2020, NutraLife BioSciences, Inc. (the "Company") issued a press
release providing a company update. A copy of this press release is attached
hereto as Exhibit 99.1 and incorporated herein by reference. The information
contained in the websites referenced in the press release are not a part of this
Current Report on Form 8-K.

The information included in Item 7.01 to this Current Report on Form 8-K shall
not be deemed to be "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to
the liabilities of that section, nor shall such information be deemed
incorporated by reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act, except as shall be expressly set forth by specific
reference in such a filing. The information set forth under this Item 7.01 shall
not be deemed an admission as to the materiality of any information in this
Current Report on Form 8-K.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits.



Exhibit No. Description
99.1 Press Release issued November 12, 2020.

© Edgar Online, source Glimpses